1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one structure
|
Common Name | 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one | ||
|---|---|---|---|---|
| CAS Number | 10517-16-5 | Molecular Weight | 268.23 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C10H12N4O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one |
|---|
| Description | 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C10H12N4O5 |
|---|---|
| Molecular Weight | 268.23 |